secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2021-09-27T23:59:59+00:00
Accession:  0001564590-21-048960
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences appoints Michael Amoroso as President and CEO, effective Oct 15, 2021
--------------------------------------------------------------------------------

- Amoroso succeeds co-founder Matt Kane, who transitions to advisor through Oct 2022.
- Annual base salary $600k; target bonus 60% of base plus $200k one-time payment in 2021.
- Inducement grants: option to buy 850k shares (4-yr vest, 25% year 1) and RSUs with $237k grant-date fair value (1-yr cliff).
- Additional option for 250k shares to be granted on first anniversary of effective date, vests over 4 years.
- Relocation assistance up to $50k (grossed up) and attorney fees up to $10k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000156459021048960/0001564590-21-048960-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000156459021048960/dtil-8k_20210927.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-048960

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer